ALBANI SALVATORE has a total of 15 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ST GEORGES ENTPR LTD, EISAI LONDON RES LAB LTD and GASTROTECH PHARMA AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 2 | |
#4 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Peptides | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Albani Salvatore | 15 |
#2 | Prakken Berent J | 4 |
#3 | Martini Alberto | 3 |
#4 | Carson Dennis A | 3 |
#5 | Tremoulet Adriana H | 1 |
Publication | Filing date | Title |
---|---|---|
US2012088678A1 | Method for prediction of response to rheumatoid arthritis therapeutics | |
WO2010104617A2 | Methods to induce a state of immune tolerance | |
WO2007130470A2 | Cytomegalovirus peptides and methods of use thereof | |
US2005208120A1 | Method of isolating antigen-specific T cells employing artificial antigen presenting cells | |
WO0180833A1 | Methods for isolation, quantification, characterization and modulation of antigen-specific t cells | |
US7022483B1 | Methods for identifying and isolating antigen-specific T cells |